JUN 21, 2018 06:00 AM PDT

Rapid Whole Genome Sequencing in the NICU and PICU Decreases Infant Morbidity and Mortality

C.E. CREDITS: P.A.C.E. CE | Florida CE


Rare disease affects 30 million people in the United States, with nearly 50% of cases affecting children. Because nearly 80% of rare diseases are genetic, advancements in genomic testing are key to pinpointing an accurate diagnosis. The Rady Children’s Institute for Genomic Medicine has engineered a Whole Genome Sequencing process to rapidly decode, analyze and interpret the root causes of rare genetic disorders in newborns and children in intensive care in a matter of days. RCIGM president and CEO Stephen Kingsmore, MD, DSc, discusses how his team is working to equip clinicians with this critical information to facilitate medical decision making. 

Show Resources
Loading Comments...